Zerlauth G, Wolf G
Biochim Biophys Acta. 1987 Mar 11;927(3):402-5. doi: 10.1016/0167-4889(87)90105-4.
The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) did not alter the binding and release kinetics of externally added 125I-labeled plasma fibronectin to human lung fibroblasts in culture. Cell layer-bound plasma fibronectin was found to be chased into the medium at the same rate in tumor-promoter-treated as in non-treated cells. Unlabeled fibronectin accumulated to a much higher degree in the medium when tumor promoter was present. We conclude that TPA does not interfere with the fibronectin receptor on substrate-attached fibroblasts, but may influence intracellular fibronectin before it is bound to the extracellular matrix.
肿瘤促进剂12 - O - 十四烷酰佛波醇-13 - 乙酸酯(TPA)并未改变体外添加的125I标记血浆纤连蛋白与培养的人肺成纤维细胞的结合及释放动力学。在肿瘤促进剂处理的细胞和未处理的细胞中,发现细胞层结合的血浆纤连蛋白以相同速率被追赶至培养基中。当存在肿瘤促进剂时,未标记的纤连蛋白在培养基中积累的程度要高得多。我们得出结论,TPA不会干扰附着于底物的成纤维细胞上的纤连蛋白受体,但可能在细胞内纤连蛋白与细胞外基质结合之前对其产生影响。